Jane Street
JUNO

Jane Street’s Juno Therapeutics, Inc. JUNO Stock Holding History

Jane Street’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-23,900
Closed -$1.09M – 5821
2017
Q4 		$1.09M Buy
23,900
+1,500
+7% +$74.8K ﹤0.01% 2244
2017
Q3 		$1M Sell
22,400
-18,100
-45% -$617K ﹤0.01% 2302
2017
Q2 		$1.21M Buy
40,500
+30,400
+301% +$750K ﹤0.01% 1993
2017
Q1 		$224K Sell
10,100
-18,800
-65% -$403K ﹤0.01% 3751
2016
Q4 		$545K Buy
+28,900
New +$707K ﹤0.01% 2769
2016
Q3 		– Sell
-24,200
Closed -$930K – 4826
2016
Q2 		$930K Buy
+24,200
New +$1M ﹤0.01% 2065
2016
Q1 		– Sell
-5,100
Closed -$224K – 4939
2015
Q4 		$224K Buy
+5,100
New +$253K ﹤0.01% 3446
2015
Q3 		– Sell
-13,200
Closed -$704K – 4460
2015
Q2 		$704K Buy
+13,200
New +$701K ﹤0.01% 1940

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Jane Street's JUNO Position: Q1 2018 in Review

Jane Street sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 16,643 shares — an estimated $761K sold.

Jane Street first reported a position in JUNO in Q4 2014 and held it in 11 quarters. The position peaked at $2.09M in Q1 2015. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • Jane Street reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Jane Street sold 16,643 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $761K.
  • Jane Street first reported a position in Juno Therapeutics, Inc. in Q4 2014 and held it in 11 quarters.
  • Jane Street's Juno Therapeutics, Inc. position peaked at $2.09M in Q1 2015.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Jane Street's 13F filing for Q1 2018, filed 15 May 2018.